Cargando…

Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa

Rhodopsin (RHO) gene mutations are a common cause of autosomal dominant retinitis pigmentosa (ADRP). The need to suppress toxic protein expression together with mutational heterogeneity pose challenges for treatment development. Mirtrons are atypical RNA interference effectors that are spliced from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orlans, Harry O., McClements, Michelle E., Barnard, Alun R., Martinez-Fernandez de la Camara, Cristina, MacLaren, Robert E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8368061/ https://www.ncbi.nlm.nih.gov/pubmed/34400638 http://dx.doi.org/10.1038/s41467-021-25204-3

Ejemplares similares

Inclusion of the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances AAV2-Driven Transduction of Mouse and Human Retina
por: Patrício, Maria I., et al.
Publicado: (2017)

CRISPR DNA Base Editing Strategies for Treating Retinitis Pigmentosa Caused by Mutations in Rhodopsin
por: Kaukonen, Maria, et al.
Publicado: (2022)

Codon-Optimized RPGR Improves Stability and Efficacy of AAV8 Gene Therapy in Two Mouse Models of X-Linked Retinitis Pigmentosa
por: Fischer, M. Dominik, et al.
Publicado: (2017)

RNA Editing as a Therapeutic Approach for Retinal Gene Therapy Requiring Long Coding Sequences
por: Fry, Lewis E., et al.
Publicado: (2020)

Immunomodulatory Effects of Hydroxychloroquine and Chloroquine in Viral Infections and Their Potential Application in Retinal Gene Therapy
por: Chandler, Laurel C., et al.
Publicado: (2020)

Knockdown and replacement therapy mediated by artificial mirtrons in spinocerebellar ataxia 7
por: Curtis, Helen J., et al.
Publicado: (2017)

Assessment of AAV Dual Vector Safety in the Abca4(−)(/)(−) Mouse Model of Stargardt Disease
por: McClements, Michelle E., et al.
Publicado: (2020)

Impact of Vital Dyes on Cell Viability and Transduction Efficiency of AAV Vectors Used in Retinal Gene Therapy Surgery: An In Vitro and In Vivo Analysis
por: Salvetti, Anna P., et al.
Publicado: (2017)

mirtronDB: a mirtron knowledge base
por: Da Fonseca, Bruno Henrique Ribeiro, et al.
Publicado: (2019)

CRISPR Interference–Potential Application in Retinal Disease
por: Peddle, Caroline F., et al.
Publicado: (2020)

Future Perspectives of Prime Editing for the Treatment of Inherited Retinal Diseases
por: Hansen, Silja, et al.
Publicado: (2023)

Developmental Expression of the Cell Cycle Regulator p16(INK4a) in Retinal Glial Cells: A Novel Marker for Immature Ocular Astrocytes?
por: Martinez-Fernandez de la Camara, Cristina, et al.
Publicado: (2023)

Accurate Quantification of AAV Vector Genomes by Quantitative PCR
por: Martinez-Fernandez de la Camara, Cristina, et al.
Publicado: (2021)

Comparing miRNA structure of mirtrons and non-mirtrons
por: Titov, Igor I., et al.
Publicado: (2018)

An analysis of the Kozak consensus in retinal genes and its relevance to gene therapy
por: McClements, Michelle E., et al.
Publicado: (2021)

 Adeno-associated Virus (AAV) Dual Vector Strategies for Gene Therapy Encoding Large Transgenes
por: McClements, Michelle E., et al.
Publicado: (2017)

Programmable RNA editing with endogenous ADAR enzymes – a feasible option for the treatment of inherited retinal disease?
por: Bellingrath, Julia-Sophia, et al.
Publicado: (2023)

Microperimetry as an Outcome Measure in RPGR-associated Retinitis Pigmentosa Clinical Trials
por: Taylor, Laura J., et al.
Publicado: (2023)

Functional expression of complement factor I following AAV-mediated gene delivery in the retina of mice and human cells
por: Dreismann, Anna K., et al.
Publicado: (2021)

Molecular Strategies for RPGR Gene Therapy
por: Cehajic Kapetanovic, Jasmina, et al.
Publicado: (2019)

Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?
por: Han, Ruofan Connie, et al.
Publicado: (2021)

Impaired glutamylation of RPGR(ORF15) underlies the cone-dominated phenotype associated with truncating distal ORF15 variants
por: Cehajic-Kapetanovic, Jasmina, et al.
Publicado: (2022)

CRISPR-Cas9 DNA Base-Editing and Prime-Editing
por: Kantor, Ariel, et al.
Publicado: (2020)

Insights on the Regeneration Potential of Müller Glia in the Mammalian Retina
por: Salman, Ahmed, et al.
Publicado: (2021)

Therapy Approaches for Stargardt Disease
por: Piotter, Elena, et al.
Publicado: (2021)

The Scope of Pathogenic ABCA4 Mutations Targetable by CRISPR DNA Base Editing Systems—A Systematic Review
por: Piotter, Elena, et al.
Publicado: (2022)

New CRISPR Tools to Correct Pathogenic Mutations in Usher Syndrome
por: Major, Lauren, et al.
Publicado: (2022)

A Review of CRISPR Tools for Treating Usher Syndrome: Applicability, Safety, Efficiency, and In Vivo Delivery
por: Major, Lauren, et al.
Publicado: (2023)

Genome-Editing Strategies for Treating Human Retinal Degenerations
por: Quinn, Joel, et al.
Publicado: (2021)

AAV Induced Expression of Human Rod and Cone Opsin in Bipolar Cells of a Mouse Model of Retinal Degeneration
por: McClements, Michelle E., et al.
Publicado: (2021)

Tropism of AAV Vectors in Photoreceptor-Like Cells of Human iPSC-Derived Retinal Organoids
por: McClements, Michelle E., et al.
Publicado: (2022)

Inclusion of PF68 Surfactant Improves Stability of rAAV Titer when Passed through a Surgical Device Used in Retinal Gene Therapy
por: Patrício, Maria I., et al.
Publicado: (2019)

Enhancement of Adeno-Associated Virus-Mediated Gene Therapy Using Hydroxychloroquine in Murine and Human Tissues
por: Chandler, Laurel C., et al.
Publicado: (2019)

Enhancement of Adeno-Associated Virus-Mediated Gene Therapy Using Hydroxychloroquine in Murine and Human Tissues
por: Chandler, Laurel C., et al.
Publicado: (2023)

Minicircle Delivery to the Neural Retina as a Gene Therapy Approach
por: Staurenghi, Federica, et al.
Publicado: (2022)

Suppression and Replacement Gene Therapy for Autosomal Dominant Disease in a Murine Model of Dominant Retinitis Pigmentosa
por: Millington-Ward, Sophia, et al.
Publicado: (2011)

Low Luminance Visual Acuity and Low Luminance Deficit in Choroideremia and RPGR-Associated Retinitis Pigmentosa
por: Wood, Laura J., et al.
Publicado: (2021)

Optogenetic Gene Therapy for the Degenerate Retina: Recent Advances
por: McClements, Michelle E., et al.
Publicado: (2020)

Assessment of the Electronic Retinal Implant Alpha AMS in Restoring Vision to Blind Patients with End-Stage Retinitis Pigmentosa
por: Edwards, Thomas L., et al.
Publicado: (2018)

Functional VEGFA knockdown with artificial 3′-tailed mirtrons defined by 5′ splice site and branch point
por: Kock, Kian Hong, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7gl9aeqi9tmksao0n2qidb8mbi